Today we have taken our first successful step in testing the feasibility of our technology. In the coming year we will build and test our first product prototype. The final result will be a new business (called Trigona Medical) set up to manufacture and sell a non-invasive blood glucose monitoring devices and ultimately a medical diagnostic platform which can revolutionize Point of Care testing. The major impact will be to our customers who could be a spouse, son or daughter; most likely everybody will know one or more of our customers personally. They could be a Type 1 diabetic, a diabetes care giver, a nurse, a doctor or any of the 500 million people involved in the treatment of Diabetes Mellitus. Our customers want us to help simplify their lives and at the same time empower them to take charge of their health and happiness.
Customers will buy from us because our product;
1 is the only non-invasive solution in the marketplace,
2 is 100% discrete,
3 requires no expensive disposables,
4 can be operated in either single or continuous measurement mode,
5 causes no pain (injury phobia)
6 has no needles (for those patients with needle phobia)
7 draws no blood ( blood/injury/needle phobia)
8 is accurate, convenient, safe and great value
9 fulfills a basic need for many diabetics and medical professionals
Deep down anyone who has to injury themselves or others to give treatment desires another “better” solution. It is a basic need in parents for their children, care providers for their patients and nearly everyone when it comes to inflicting pain on themselves or on others; do no harm!
In a recent study of medical professionals, up to 35% of the participants stated that pain is the main reason people with diabetes refrain from regular blood glucose testing.
In building a business like Trigona Medical we are bringing together highly skilled people to work together and will work together with our partners to achieve our goals. Today we are working with a core team of 5 people and 6 European partners, in the future we plan to build a business with 60 employees, working with 30 partners worldwide making 3.4 million products each year and generating over 550 million Euro revenue per annum.
From a socio-economic perspective the global diabetes population will rise to 590 million by 2035, a 55% increase and a huge global burden for healthcare services. The greatest risk from diabetes is the variety of complications it causes, which continuously increase the cost of medical care. In 2013, global expenditure on diabetes care was around 300 billion Euros, which accounts for 11.6% of all human medical expenses, and it ranks as one of the top five diseases in the medical expense budgets for all countries. However, these huge medical expenses are primarily attributed to improper glycemic control by diabetic patients, which leads to complications. To effectively avoid the occurrence of complications, health care authorities around the world are working continuously to advocate the strengthening of health education for patients with diabetes, so as to improve the effectiveness of glycemic control by diabetes patients. This effort also spurs the continuous increase in the demand for improved blood glucose monitoring products.
